Cited by 70Multiple Sclerosis Research StudiesT-cell and B-cell ImmunologyPsoriasis: Treatment and Pathogenesis

Neuropathologic, phenotypic and functional analyses of Mucosal Associated Invariant T cells in Multiple Sclerosis

Salou, Marion, Nicol, Bryan, Garcia, Alexandra, Baron, Daniel, Michel, Laure, Elong-Ngono, Annie, Hulin, Philippe, Nedellec, Steven +10 more·2016·Clinical Immunology

Abstract

Background The involvement of Mucosal Associated Invariant T (MAIT) cells, which are anti-microbial semi-invariant T cells, remains elusive in Multiple Sclerosis (MS). Objective Deciphering the potential involvement of MAIT cells in the MS inflammatory process. Methods By flow cytometry, blood MAIT cells from similar cohorts of MS patients and healthy volunteers (HV) were compared for frequency, phenotype, activation potential after in vitro TCR engagement by bacterial ligands and transmigration abilities through an in vitro model of blood-brain barrier. MS CNS samples were also studied by immunofluorescent staining and quantitative PCR. Results and conclusion Blood MAIT cells from relapsing-remitting MS patients and HV presented similar frequency, ex vivo effector phenotype and activation abilities. MAIT cells represented 0.5% of the total infiltrating T cells on 39 MS CNS lesions. This is low as compared to blood frequency (p<0.001), but consistent with their low transmigration rate. Finally, transcriptional over-expression of MR1 - which presents cognate antigens to MAIT cells - and of the activating cytokines IL-18 and IL-23 was evidenced in MS lesions, suggesting that the CNS microenvironment is suited to activate the few infiltrating MAIT cells. Taken together, these data place MAIT cells from MS patients as minor components of the inflammatory pathological process.

Integrity signals

Registry

Crossref · 10.1016/j.clim.2016.03.014

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Salou, M., Nicol, B., Garcia, A., Baron, D., Michel, L., Elong-Ngono, A., Hulin, P., Nedellec, S., Jacq-Foucher, M., Le Frère, F., Jousset, N., Bourreille, A., Wiertlewski, S., Soulillou, J.-P., Brouard, S., Nicot, A. B., Degauque, N., & Laplaud, D.-A.
Affiliations
  • Inserm (FR)
  • Structure Fédérative de Recherche Bonamy (FR)
Corresponding author
Laplaud, David-Axel
Venue
Clinical Immunology
Publisher
Elsevier BV
Published
2016-05
Volume
166-167
Pages
1-11
ISSN
1521-6616 (ISSN-L)
OpenAlex
W2326249228
Cited by
70
References
2
Citations by year
2026: 5 · 2025: 4 · 2024: 12 · 2023: 7 · 2022: 5 · 2021: 7 · 2020: 7 · 2019: 8 · 2018: 6 · 2017: 7 · 2016: 2
FWCI
6.96
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Immunology (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Funders
  • ARSEP Foundation
  • ANTARES Association
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
Keywords
mucosal-associated invariant T cells, multiple sclerosis, relapsing-remitting multiple sclerosis, MR1, IL-18, IL-23, central nervous system lesions, T cell activation, neuroinflammation
MeSH terms
Mucosal-Associated Invariant T Cells, Adult, Blood-Brain Barrier, Brain, Cell Movement, Female, Gene Expression Regulation, Humans, Male, Middle Aged, Models, Biological, Receptors, Antigen, T-Cell, Histocompatibility Antigens Class I, Minor Histocompatibility Antigens, Case-Control Studies, Immunophenotyping, Immunity, Mucosal, Interleukin-18, Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Relapsing-Remitting, Interleukin-23

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review